Nordic Bioproducts Group

Nordic Bioproducts Group_Logo

 

Your Nordic Partner for
Sustainable MCC

 

* Quality

* Purity

* Safety

* Sustainability

 

Nordic Bioproducts Group, a spin-off from Aalto University, stands at the forefront of cellulose innovation, smart technology, and commercialization in the Nordics.

As a pioneering force in sustainable Microcrystalline Cellulose production, we are dedicated to introducing breakthrough products that redefine the landscape of sustainable solutions for the pharmaceutical industry.

Using locally sourced, renewable raw materials, smart technologies, and sustainable production processes, we deliver environmentally conscious products for Pharmaceuticals that meet the highest standards of quality, purity, safety and sustainability.

 

Our patented AaltoCellTM technology opens a whole new world

for sustainable Microcrystalline Cellulose production.

News Nordic BioProducts Group

Nordic Bioproducts Group_MCC

Powered by our patented AaltoCell™ technology, our state-of-the-art facility represents a significant advancement in Microcrystalline Cellulose production, product quality, and performance.

Featuring the world’s first continuous production line of up to 10,000 tons of MCC annually, our facility was designed to ensure quality and purity in MCC production. It also guarantees environmental sustainability by producing zero solid waste and using only a fraction of the chemicals, water, and electricity compared to traditional MCC production processes.

 

69% less chemicals

95% less water

90% less energy

81% lower GWP

 

*Based on an independent, third-party lifecycle analysis (LCA) when compared to traditional methods.

 

MCC Production Achievements

Supported by a comprehensive LCA study, our process sets a new standard in Microcrystalline Cellulose production.

  1. Reduced Greenhouse Gas Emissions The third-party LCA on our Lappeenranta production facility demonstrates a significant reduction in greenhouse gas emissions compared to traditional methods. The GWP of AaltoCell™ MCC is 434.6 kg CO2 eq/ton, 81% lower than all cases studied.
  2. Sustainable Local Raw Material Sourcing Nordic Bioproducts Group uses traceable, locally sourced FSC-certified softwood paper pulp derived from a sulfate process, which has a lower environmental impact compared to the sulfite process used in traditional MCC production.
  3. 100% Green Energy Utilization Our facility uses 100% certified renewable electricity minimizing reliance on fossil fuels.
  4. Efficient Process and Transportation European production with short transportation distances for raw materials, and efficient use of chemical and water contribute to a lower environmental impact.
  5. Comprehensive Environmental Impact Reduction Beyond GWP, our technology exhibits lower impacts across almost all other environmental categories compared to traditional MCC production.
  6. Continuous Manufacturing Transitioning from batch to continuous production improves raw material utilization, reduces waste, and leads to cost savings.
Nordic Bioproducts Group_MCC Tablet
MCC pura, Image: Nordic Bioproducts Group

 

  • Nitrite Impurity Reduction Our technology significantly reduces nitrite impurities, ensuring safer and higher quality products. (Link to certificate)
  • Pre-commercial samples show nitrite content consistently at <0.1ppm, minimizing nitrosamine risk.
  • Proven Product Properties Our Microcrystalline Cellulose features enhanced flowability, high bulk density, and purity with no black spots.
  • We follow GMP protocol and Pharmacopeia Standard
Nordic Bioproducts Group_MCC 2
MCC pura, Image: Nordic Bioproducts Group

Nordic Bioproducts Group_Excipact

Certifications Our facility and processes are ISO 9001:2015 and EXCiPACT certified, ensuring high standards of quality management and good manufacturing practices.

More information on Nordic Bioproducts Group